JP2023539341A5 - - Google Patents
Info
- Publication number
- JP2023539341A5 JP2023539341A5 JP2023514067A JP2023514067A JP2023539341A5 JP 2023539341 A5 JP2023539341 A5 JP 2023539341A5 JP 2023514067 A JP2023514067 A JP 2023514067A JP 2023514067 A JP2023514067 A JP 2023514067A JP 2023539341 A5 JP2023539341 A5 JP 2023539341A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073304P | 2020-09-01 | 2020-09-01 | |
| US63/073,304 | 2020-09-01 | ||
| PCT/US2021/048611 WO2022051332A1 (en) | 2020-09-01 | 2021-09-01 | Dux4 inhibitors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539341A JP2023539341A (ja) | 2023-09-13 |
| JP2023539341A5 true JP2023539341A5 (https=) | 2024-08-23 |
| JPWO2022051332A5 JPWO2022051332A5 (https=) | 2024-08-23 |
Family
ID=80492176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514067A Pending JP2023539341A (ja) | 2020-09-01 | 2021-09-01 | Ｄｕｘ４阻害剤およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230348906A1 (https=) |
| EP (1) | EP4208548A4 (https=) |
| JP (1) | JP2023539341A (https=) |
| AR (1) | AR123420A1 (https=) |
| AU (1) | AU2021337595A1 (https=) |
| CA (1) | CA3189861A1 (https=) |
| TW (1) | TW202227626A (https=) |
| WO (1) | WO2022051332A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11555190B2 (en) | 2020-03-19 | 2023-01-17 | Avidity Biosciences, Inc. | Compositions and methods of treating Facioscapulohumeral muscular dystrophy |
| CA3174286A1 (en) | 2020-04-02 | 2021-10-07 | Robert PLACE | Targeted inhibition using engineered oligonucleotides |
| IL301187A (en) | 2020-09-11 | 2023-05-01 | Arrowhead Pharmaceuticals Inc | RNAi agents for suppressing DUX4 expression, preparations containing them and uses thereof |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| MX2024003266A (es) | 2021-09-16 | 2024-04-03 | Avidity Biosciences Inc | Composiciones y metodos de tratamiento de la distrofia muscular facioescapulohumeral. |
| WO2023185946A1 (zh) * | 2022-03-30 | 2023-10-05 | 苏州瑞博生物技术股份有限公司 | 一种寡核苷酸缀合物、含有该寡核苷酸缀合物的组合物及制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305812A3 (en) * | 2002-11-14 | 2012-06-06 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| WO2012024535A2 (en) * | 2010-08-18 | 2012-02-23 | Fred Hutchinson Cancer Research Center | Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd) |
| AU2012286994B2 (en) * | 2011-07-25 | 2017-08-10 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of DUX4 |
| US10538763B2 (en) * | 2015-01-16 | 2020-01-21 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulation of DUX4 |
| AU2018345772B2 (en) * | 2017-10-02 | 2025-04-17 | Research Institute At Nationwide Children's Hospital | MiRNA detargeting system for tissue specific interference |
| IL279102B2 (en) * | 2018-05-30 | 2024-10-01 | Dtx Pharma Inc | Lipid-modified nucleic acid compounds and methods |
| WO2020028134A1 (en) * | 2018-07-30 | 2020-02-06 | Fred Hutchinson Cancer Research Center | Methods and compositions for treating cancer |
| US20220193250A1 (en) * | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
-
2021
- 2021-09-01 AR ARP210102453A patent/AR123420A1/es unknown
- 2021-09-01 US US18/043,520 patent/US20230348906A1/en active Pending
- 2021-09-01 WO PCT/US2021/048611 patent/WO2022051332A1/en not_active Ceased
- 2021-09-01 CA CA3189861A patent/CA3189861A1/en active Pending
- 2021-09-01 JP JP2023514067A patent/JP2023539341A/ja active Pending
- 2021-09-01 EP EP21865016.6A patent/EP4208548A4/en active Pending
- 2021-09-01 TW TW110132422A patent/TW202227626A/zh unknown
- 2021-09-01 AU AU2021337595A patent/AU2021337595A1/en active Pending